Navigation Links
European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient

GHENT, Belgium, Dec. 15 /PRNewswire-FirstCall/ -- Ghent University Hospital in Belgium, among the first hospitals in the world to pioneer radiotherapy treatments using arc therapy, has carried out its first treatment using fast and efficient RapidArc radiotherapy technology from Varian Medical Systems ( VAR). A 56-year-old male rectal carcinoma patient was treated in just 75 seconds, over four times faster than possible using conventional fixed-beam treatments.

"This treatment would have taken more than five minutes using conventional intensity-modulated radiotherapy and such time-savings are very important both for the wellbeing of the patient and the efficiency of the hospital," said Professor Marc van Eijkeren, head of Ghent University Hospital's Department of Radiation Oncology. "We were able to achieve an increase in dose to the tumor while using far fewer monitor units of radiation to achieve this. Indeed, there was threefold reduction in monitor units used, which is helpful in tissue sparing and increasing patient comfort."

"We are a busy university hospital and we are under constant strain to deliver advanced IMRT treatments within our standard 15 minutes treatments slots," he added. "With RapidArc, that will no longer be a problem as we will be able to offer advanced conformal treatments to more patients while reducing our treatment slot times."

Professor van Eijkeren said the patient's treatment involved treating the rectum, pelvis and lymph nodes in a single arc - or revolution - of the Clinac® iX medical linear accelerator. All such rectal treatments will now be carried out using the RapidArc technique and the team at Ghent also plans to begin using RapidArc for other cancers in the pelvic region.

Physicist Leen Paelinck said Eclipse(TM) treatment planning software was quick and simple to use, reducing the planning time substantially. "The planning process involves contouring, optimization, calculation and evaluation and Eclipse enables us to undertake this process more quickly than was previously possible," said Leen Paelinck.

Professor van Eijkeren says his hospital's long history with advanced techniques such as arc therapy comes from its goal of gaining greater tumor control and fewer side effects. Ghent University Hospital serves more than 1.5 million people in the northern regions of Belgium.

"Ghent University Hospital is unique in its long experience in volumetric intensity modulated arc treatments and its adoption of RapidArc as the best solution for this patient and others is a significant step forward," says Vincent Ronfle, Varian's regional sales manager. "Such milestones are helpful in understanding the present and future applications of this technology in our efforts to improve treatments for patients."

RapidArc delivers a volumetric intensity-modulated radiation therapy treatment in a single or multiple arcs of the treatment machine around the patient and makes it possible to deliver advanced image-guided IMRT two to eight times faster than is possible with conventional IMRT. Since its introduction last year, more than 270 RapidArc systems have been installed in hospitals globally.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, China, and Europe and in its 79 sales and support offices around the world. For more information, visit

SOURCE Varian Medical Systems, Inc.

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. A Drugs Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections
2. Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8
3. Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)
4. Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis
5. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
6. European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis
7. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
8. BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries
9. Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Reportlinker Adds European Markets for Spinal Implants, MIS, and VCF 2009 (15 Countries)
Post Your Comments:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
Breaking Medicine News(10 mins):